Skip to content

上市筹备 · 2026-01-18

Preparing the Working Capital Sufficiency Statement for Your HKEX Application

The HKEX’s Listing Committee has, since the start of 2025, flagged working capital sufficiency as a recurring deficiency in at least 27% of rejected Main Board applications reviewed in Q1 2025, according to internal HKEX training materials circulated to sponsors in March. This marks a 12-percentage-point increase from the 15% rejection rate attributed to this issue in the same period of 2024. The shift is not arbitrary. The SFC and HKEX jointly published a revised “Guidance on Due Diligence for Listing Applications” in December 2024 (SFC/HKEX Joint Statement, December 2024), which explicitly elevated working capital verification from a procedural check to a substantive sponsor obligation. For CFOs and company secretaries preparing a listing application under the Main Board or GEM Listing Rules, the working capital sufficiency statement is no longer a form letter attached to the prospectus. It is a document that the Listing Division will test against bank statements, supplier contracts, and historical cash conversion cycles. Any gap between the statement and the underlying evidence can trigger an iterative round of RFIs that delays the listing timetable by four to six weeks. This article dissects the regulatory requirements, the practical preparation process, and the specific documentation that sponsors and applicants must align before filing the A1 application.

The Regulatory Framework Underlying the Statement

Main Board Rule 11.18 and GEM Rule 11.24

The primary obligation sits in Main Board Listing Rule 11.18 and GEM Listing Rule 11.24. Both require that a listing document contain a statement by the directors that, in their opinion, the group has sufficient working capital for its present requirements for at least the next 12 months from the date of the prospectus. The statement must be supported by a memorandum from the sponsor confirming that the directors’ opinion has been reached after due and careful enquiry. The rule does not prescribe a specific format for the memorandum, but HKEX practice guidance (PG-1, “Working Capital Sufficiency Statements”, last updated October 2023) requires the sponsor to detail the basis of its review, including the assumptions, the sources of liquidity, and the sensitivity analysis applied.

The December 2024 Joint Statement’s Impact on Sponsor Due Diligence

The SFC/HKEX Joint Statement of December 2024 (the “Joint Statement”) directly addresses working capital verification under Section 3.2. It states that sponsors must not rely solely on management representations or unaudited management accounts. Instead, sponsors must independently verify the cash flow projections against third-party evidence. For example, if the projection assumes a 30-day extension of supplier payment terms, the sponsor must obtain written confirmation from the top five suppliers by value, or alternatively, review the supplier contracts to confirm that a 30-day extension is contractually permissible and has been consistently applied in practice. The Joint Statement cites a specific enforcement case (SFC v. Sponsor A, 2024, unreported) where a sponsor failed to verify a 45-day receivable collection assumption, and the issuer subsequently experienced a liquidity shortfall within six months of listing. The SFC imposed a fine of HKD 27 million on the sponsor.

Structuring the Cash Flow Projection Model

The 12-Month Horizon and the Base Case Assumptions

The cash flow projection must cover a continuous 12-month period from the expected date of the prospectus, not from the date of the A1 filing. This distinction matters because the HKEX review process typically takes three to four months. If the sponsor prepares the projection in month one, but the listing occurs in month five, the projection must be rolled forward to cover 12 months from the new prospectus date. Practitioners commonly build a 15-month model to provide a three-month buffer against review delays. The base case assumptions must include: (i) revenue growth rates derived from historical revenue data for the most recent 24 months, not from management targets; (ii) gross margin percentages supported by audited financial statements for at least the three most recent financial years; (iii) operating expense ratios calculated as a percentage of revenue, with any step-change justified by a specific, documented cost driver (e.g., a new lease for a larger warehouse); and (iv) capital expenditure commitments that match board-approved budgets and signed purchase orders.

Sensitivity Analysis: The 80/20 Rule

HKEX practice guidance expects at least three downside scenarios: (i) a 20% decline in revenue; (ii) a 30-day lengthening of the receivables collection period; and (iii) a 10% increase in raw material costs. The sponsor must demonstrate that even under the most severe scenario, the group retains a positive cash balance at the end of the 12-month period. If the model shows a cash shortfall under any scenario, the applicant must identify a committed source of bridge financing, such as a standby facility from a licensed bank in Hong Kong (HKMA-authorised institution) or a binding letter of credit from a parent company. Uncommitted overdraft lines or verbal assurances from shareholders do not satisfy the rule. The HKEX has, in at least three published decisions in 2024 (HKEX Listing Decision LD123-2024, LD124-2024, and LD125-2024), rejected applications where the sponsor relied on uncommitted facilities.

Documentation and Evidence Collection

The Sponsor’s Memorandum Structure

The sponsor’s memorandum must be a standalone document, typically 15 to 25 pages, structured as follows: (i) executive summary stating the opinion and the material assumptions; (ii) description of the group’s business model and cash flow drivers; (iii) detailed assumptions for each line item in the cash flow projection, cross-referenced to supporting evidence; (iv) sensitivity analysis tables; (v) confirmation of committed facilities, including copies of facility letters; (vi) a section on any contingent liabilities that could crystallise within the 12-month period (e.g., pending litigation, tax disputes, or performance guarantees); and (vii) a sign-off page signed by the sponsor’s principal and the director responsible for the engagement.

Evidence Required for Each Assumption

The Joint Statement requires that each assumption be backed by a specific document type. For revenue assumptions: signed customer contracts or purchase orders for the projection period, not just historical invoices. If the revenue is derived from a recurring subscription model, the sponsor must confirm the renewal rate based on the latest 12 months of churn data. For cost assumptions: supplier contracts, price lists, or quotes from at least three suppliers for each major raw material. For working capital assumptions: aged receivables and payables reports as of the most recent month-end, plus a schedule of historical collection and payment cycles for the preceding 24 months. For debt servicing: repayment schedules from each lender, including the applicable interest rate and any covenant ratios. For capital expenditure: board minutes approving the capex budget and signed contracts with equipment vendors.

Common Pitfalls and How to Avoid Them

Overly Optimistic Revenue Growth Projections

The most common pitfall, cited in 68% of rejected applications reviewed by the HKEX Listing Division in 2024, is projecting revenue growth that exceeds the historical compound annual growth rate (CAGR) without a documented, contracted reason. If the applicant’s historical CAGR is 12% but the projection assumes 25% growth, the sponsor must identify a specific, binding contract that accounts for the incremental 13%. A sales pipeline report or a letter of intent does not constitute sufficient evidence. The HKEX has, in LD124-2024, specifically stated that “projected growth must be demonstrably anchored in contractual commitments or regulatory approvals that have been obtained.”

Ignoring Seasonality and Working Capital Cycles

A second recurring issue is the failure to model seasonal cash flow patterns. If the applicant’s business is retail or export-oriented, with peak sales in Q4, the projection must show the cash build-up in Q3 to fund inventory purchases, and the subsequent drawdown in Q1 when receivables are collected. A linear monthly projection that smooths out seasonality will be rejected. The sponsor must provide monthly cash flow statements for the preceding 24 months to establish the seasonal pattern, and then apply the same pattern to the projection period, adjusted for any known changes in the business cycle.

Contingent Liabilities Not Disclosed

The directors’ statement must address contingent liabilities that could materialise within the 12-month period. If the group is party to litigation with a potential liability exceeding HKD 5 million, the sponsor must obtain a legal opinion from the applicant’s Hong Kong solicitors assessing the probability of an adverse outcome and the likely quantum. If the probability is assessed as “more likely than not,” the projection must include a cash outflow equal to the full quantum. If the probability is “less than likely,” the sponsor must still disclose the contingency in the memorandum and explain why no cash outflow is included.

Actionable Takeaways

  1. Begin building the cash flow projection model at least 16 weeks before the intended A1 filing date, using a 15-month horizon to absorb regulatory review delays.
  2. Obtain signed customer contracts and supplier agreements for the projection period, not just historical data, to satisfy the Joint Statement’s independent verification requirement.
  3. Run three downside sensitivity scenarios — a 20% revenue decline, a 30-day receivable extension, and a 10% cost increase — and ensure the model remains cash-positive under all three.
  4. Secure a committed standby facility from an HKMA-authorised institution or a binding parent company guarantee before the sponsor signs off on the memorandum.
  5. Disclose all contingent liabilities exceeding HKD 5 million with a supporting legal opinion from a Hong Kong law firm, and include a cash outflow in the projection if the probability of crystallisation is assessed as more likely than not.